ADVENTRX Pharmaceuticals has nabbed $20 million in a private placement of its common stock and warrants. Investment funds controlled by Carl Icahn were the largest investors in the transaction, together with Viking Global Investors. Company executives said the proceeds will feed development of its lead compound CoFactor, among other things.
- read this AP report for more